Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Appendix B: Glossary
accuracy |
Closeness of agreement between a measurement result and the true value or the accepted reference value |
alternative performance assessment |
Quality assessment activities for a test for which proficiency testing is not available or not used for the purpose of verifying the accuracy of the test results |
amino acid |
Basic structural units of proteins, the measurement of which (in protein and peptide hydrolysates, physiological fluids, and numerous other samples) provide important information for fundamental studies and the diagnosis of many pathological conditions, especially those resulting from inborn errors of metabolism |
analyte |
Component represented in the name of a measurable quantity |
analyte-specific reagent |
Antibodies (both polyclonal and monoclonal), specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reactions with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens (21 CFR §864.4020[a]) |
analytical sensitivity |
In quantitative testing: the change in response of a measuring system or instrument divided by the corresponding change in the stimulus; in qualitative testing: the test method's ability to obtain positive results in concordance with positive results obtained by the reference method |
analytical specificity |
Ability of a measurement procedure to measure solely the measurand |
biochemical genetic testing |
A diverse spectrum of laboratory analyses of metabolites, enzyme activities, and functional assays for evaluation, diagnosis, treatment monitoring, disease management, and assessing a person's risk for carrying a specific disease trait (i.e., carrier status assessment), such as inborn errors of metabolism |
clinical sensitivity |
The proportion of patients with a well-defined clinical disorder whose test values are positive or exceed a defined decision limit |
clinical specificity |
The proportion of patients who do not have a specified clinical disorder whose test results are negative or within the defined decision limit |
clinical validity |
The accuracy with which a test predicts designated intermediate or final clinical outcomes |
competency assessment |
Evaluation of a person's ability to perform a test, including all aspects of testing, from specimen collection to reporting of results |
confirmatory test |
A test to prove or disprove the presence of a specific condition identified by screening tests (for newborn screening using dried blood spot specimens, this testing is from a specimen other than the screening specimen) |
control material |
A device, solution, or lyophilized preparation intended for use in the quality control process to monitor the reliability of a test system and to maintain its performance within established limits |
current procedural terminology (CPT) codes |
Current procedural terminology code set maintained by the American Medical Association |
critical values |
Test results that require immediate notification of the clinician for patient evaluation or treatment |
cut-off value |
Quantitative value of the analyte that is used as the decision point between a positive and a negative result |
drift |
A slow or systematic change of a metrological characteristic of a measuring instrument or system, such as accuracy, trueness, and precision |
genetics |
The study of inheritance patterns of specific traits |
genome |
The complete genetic content of an organism |
genotype |
The genetic makeup of an organism or group of organisms with reference to a single trait, set of traits, or an entire complex of traits |
Health Level Seven |
A standards-development organization that has produced international standards for electronic reporting of laboratory results and orders |
in-range result |
Newborn screening result that is within the expected range of normal or negative test results established for a particular condition |
informed consent |
A process by which persons voluntarily confirm their willingness to participate in a particular testing act after having been informed of all aspects of the act that are relevant to the decision to participate in the act |
internal control material |
A control material that is placed in the same reaction tube as the specimen being analyzed and therefore is subjected to exactly the same internal conditions and external parameters as any analyte present in the tube |
International Classification of Diseases (ICD) |
The international standard diagnostic classification for the coding of diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases, as maintained by the World Health Organization |
limit of detection (LOD) |
The lowest amount of analyte in a sample that can be detected (with stated probability), although the amount might not be quantified as an exact value |
limit of quantitation (LOQ) |
The lowest concentration at which an analyte can be quantitatively determined with stated acceptable precision and trueness under stated experimental conditions; might be equal to the limit of detection or could be at a higher concentration |
measurand |
Quantity to be measured |
newborn screening |
A system that identifies, shortly after birth, infants who are at increased risk for genetic and other congenital conditions so that treatment can begin as soon as possible; need to confirm positive newborn screening results with additional diagnostic testing |
nonwaived testing |
Test systems, assays, or examinations that have not been determined to be waived testing. Nonwaived testing encompasses moderate- and high-complexity testing for which CLIA regulations provide requirements for laboratory certification, quality systems, performance assessment, and laboratory personnel |
out-of-range result |
Newborn screening result that is outside the expected range of normal or negative test results established for a particular condition, including carrier results and any need for additional testing |
phenotype |
The observed biochemical, physiological, and morphological characteristics of an individual as determined by the genotype and the environment in which the genotype is expressed; also, in a more limited sense, the expression of a particular gene or genes |
precision |
Closeness of agreement between independent test results from the same sample obtained under stipulated conditions, often determined by assessing repeatability and reproducibility |
proficiency testing |
A program in which multiple samples are periodically sent to members of a group of laboratories for analysis or identification (or both) in which each laboratory's results are compared with those of other laboratories in the group or with an assigned value (or both) and are reported to the participating laboratory and others |
repeatability |
Closeness of agreement between independent test results for the same measurand under the same conditions |
reproducibility |
Closeness of agreement between independent test results for the same measurand under changed conditions |
qualitative test |
A characterization applied to laboratory tests that detect or identify a particular analyte, constituent, or condition |
quality assessment |
A group of activities to monitor and evaluate the total testing process to help ensure that test results are reliable, improve the testing process, and promote good quality testing practices |
quality control |
Operational techniques and activities that are used to fulfill requirements for quality; the procedures used to detect and correct errors that occur due to test system failure, adverse environmental conditions, and variance in operator performance, as well as the monitoring of the accuracy and precision of the test performance over time |
quality management system (QMS) |
Coordinated activities to direct and control an organization with regard to quality |
quantitative test |
A characterization applied to laboratory tests that provide results expressed in a numerical amount or level (concentration) of an analyte in a sample or specimen |
reagent |
A substance that produces a chemical or biological reaction with a patient specimen that allows detection or measurement of the analyte for which the test is designed |
reference interval |
The range of test values expected for a designated population of persons (e.g., 95% of persons that are presumed to be healthy [or normal]) |
reference material |
Material sufficiently homogeneous and stable with respect to one or more specified properties (quantitative or qualitative) that has been established to be fit for its intended use in a measurement process; might be used to calibrate a measurement system, to assess a measurement procedure, to assign values to other materials, and for quality control; can only be used for a single purpose in a given measurement |
reportable range of test results |
The span of test result values over which the laboratory can establish or verify the accuracy of the instrument or test system measurement response |
total testing process |
Series of activities or path of workflow for performing testing that can be divided into three major phases: preanalytic, analytic, and postanalytic |
trueness |
Closeness of agreement between the average of an infinite number of replicate-measured quantity values and a reference quantity value |
waived test |
A test system, an assay, or an examination that has been found to meet the statutory criteria specified in the Public Health Service Act (§353[d][3]) (12) |
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.